Uptake of NO-releasing drugs by the P2 nucleoside transporter in trypanosomes

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 11, 1999, Pages 1447-1452

  Soulere L ^a   Hoffmann, P ^a,b   Bringaud, F ^a   Perie J ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Adenosine; Nitric oxide; Peroxynitrite; S nitrosothiol; Thionitrite

Indexed keywords

MELARSOPROL; NITRIC OXIDE; NUCLEOSIDE; PENTAMIDINE; PEROXYNITRITE; SUPEROXIDE DISMUTASE;

ANTIPROTOZOAL ACTIVITY; CELL MEDIATED CYTOTOXICITY; CONFERENCE PAPER; DRUG TARGETING; DRUG UPTAKE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; NONHUMAN; TRYPANOSOMA;

EID: 0344560596     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999001100016     Document Type: Conference Paper

References (35)

1. Kuzoe FA (1993). Current situation of African trypanosomiasis. Acta Tropica, 54: 153-162.
2. Fairlamb AH, Blackburn P, Ulrich P, Chait BT & Cerami A (1985). Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science, 227: 1485-1487.
3. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288: 373-376.
4. Palmer RM, Ferrige AG & Moncada S (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327: 524-526.
5. Ignarro LJ, Buga GM, Wood KS, Byrns RE & Chaudhuri G (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences, USA, 84: 9265-9269.
6. Nathan C (1992). Nitric oxide as a secretory product of mammalian cells. FASEB Journal, 6: 3051-3064.
7. Hibbs Jr JB, Vavrin Z & Taintor RR (1987). L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. Journal of Immunology, 138: 550-565.
8. Stuehr DJ & Nathan CF (1989). Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Journal of Experimental Medicine, 169: 1543-1555.
9. Mabbott NA, Sutherland IA & Sternberg JM (1995). Suppressor macrophages in Trypanosoma brucei infection: nitric oxide is related to both suppressive activity and lifespan in vivo. Parasite Immunology, 17: 143-150.
10. Green SJ, Meltzer MS, Hibbs Jr JB & Nacy CA (1990). Activated macrophages destroy intracellular Leishmania major a-mastigotes by an L-arginine-dependent killing mechanism. Journal of Immunology, 144: 278-283.
11. Liew FY, Li Y & Millott S (1990). Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. Journal of Immunology, 145: 4306-4310.
12. Green SJ, Nacy CA & Meltzer MS (1991). Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. Journal of Leukocyte Biology, 50: 93-103.
13. Lancaster Jr JR & Hibbs Jr JB (1990). EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proceedings of the National Academy of Sciences, USA, 87: 1223-1227.
14. Drapier JC & Hibbs Jr JB (1986). Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. Journal of Clinical Investigation, 78: 790-797.
15. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ & Loscalzo J (1992). S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proceedings of the National Academy of Sciences, USA, 89: 444-448.
16. Becker K, Savvides SN, Keese M, Schirmer RH & Karplus PA (1998). Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nature Structural Biology, 5: 267-271.
17. Huie RE & Padmaja S (1993). The reaction of NO with superoxide. Free Radical Research Communications, 18: 195-199.
18. Koppenol WH (1998). The basic chemistry of nitrogen monoxide and peroxinitrite. Free Radical Biology and Medicine, 25: 385-391.
19. Squadrito GL & Pryor WA (1998). Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radical Biology and Medicine, 25: 392-403.
20. Denicola A, Rubbo H, Rodriguez D & Radi R (1993). Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Archives of Biochemistry and Biophysics, 304: 279-286.
21. Rubbo H, Denicola A & Radi R (1994). Peroxynitrite inactivates thiol-containing enzymes of Trypanosoma cruzi energetic metabolism and inhibits cell respiration. Archives of Biochemistry and Biophysics, 308: 96-102.
22. Carter NS & Fairlamb AH (1993). Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature, 361: 173-176.
23. Carter NS, Berger BJ & Fairlamb AH (1995). Uptake of diamine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. Journal of Biological Chemistry, 270: 28153-28157.
24. Tye CK, Kasinathan G, Barrett MP, Brun R, Doyle VE, Fairlamb AH, Weaver R & Gilbert IH (1998). An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes. Bioorganic and Medicinal Chemistry Letters, 8: 811-816.
25. Barrett MP, Zhang ZQ, Denise H, Giroud C & Baltz T (1995). A diamine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Molecular and Biochemical Parasitology, 73: 223-229.
26. Field L, Dilts RV, Ravichandran R, Lenhert PG & Carnahan GE (1978). An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. Journal of the Chemical Society, Chemical Communications, 249-250.
27. Al-Zaidi SMR, Crilley MM & Stoodley RJ (1983). Studies related to thietan-2-ones. Part 1. Conversion of penicillamine into DL-2-methylpenicillamine using thietan-2-one-based chemistry. Journal of the Chemical Society. Perkin Transactions I, 2259-2265.
28. Moynihan HA & Roberts SM (1994). Preparation of some novel S-nitroso compounds as potential slow-release agents of nitric oxide in vivo. Journal of the Chemical Society. Perkin Transactions I, 797-805.
29. Griffith OW & Stuehr DJ (1995). Nitric oxide synthases: properties and catalytic mechanism. Annual Review of Physiology, 57: 707-736.
30. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR & Loscalzo J (1992). Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proceedings of the National Academy of Sciences, USA, 89: 7674-7677.
31. Singh SP, Wishnok JS, Keshive M, Deen WM & Tannenbaum SR (1996). The chemistry of the S-nitrosoglutathione/glutathione system. Proceedings of the National Academy of Sciences, USA, 93: 14428-14433.
32. Roy B, du Moulinet d'Hardemare A & Fontecave M (1994). New thionitrites: synthesis, stability, and nitric oxide generation. Journal of Organic Chemistry, 59: 7019-7026.
33. 2+ of nitric oxide release from S-nitrosothiols (RSNO). Journal of the Chemical Society. Perkin Transactions II, 741-745.
34. Williams DLH (1996). The mechanism of nitric oxide formation from S-nitrosothiols (thionitrites). Journal of the Chemical Society, Chemical Communications, 1085-1091.
35. Petit C, Hoffmann P, Souchard JP & Labidalle S (1997). Synthesis and characterization of new aromatic thionitrites. Phosphorus, Sulfur, and Silicon and the Related Elements, 129: 59-67.